Zepp Health Corp
NYSE:ZEPP
Zepp Health Corp
NYSE:ZEPP
Price:
13.41
USD
-4.28%
Market Closed
Market Cap:
$182.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zepp Health Corp
NYSE:ZEPP
|
CN |
|
C
|
Century Petroleum Corp
OTC:CYPE
|
US |
|
O
|
Obio Technology Shanghai Corp Ltd
SSE:688238
|
CN |
|
N
|
Nakayo Inc
TSE:6715
|
JP |
|
Run Long Construction Co Ltd
TWSE:1808
|
TW |
|
AGI Infra Ltd
BSE:539042
|
IN |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
C
|
Copernicus Securities SA
WSE:CRS
|
PL |
|
Gansu Yasheng Industrial Group Co Ltd
SSE:600108
|
CN |
|
H
|
Hlt Global Bhd
KLSE:HLT
|
MY |
|
Acrux Ltd
ASX:ACR
|
AU |
|
Champion Building Materials Co Ltd
TWSE:1806
|
TW |
|
A
|
AngloGold Ashanti Ltd
XBER:AOD1
|
ZA |
|
S2 Resources Ltd
ASX:S2R
|
AU |
|
N
|
Nippon Television Holdings Inc
TSE:9404
|
JP |
Income Statement
Earnings Waterfall
Zepp Health Corp
Zepp Health Corp
Income Statement
Zepp Health Corp
Zepp Health Corp
Currency: CNY
| Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
7
|
8
|
8
|
8
|
8
|
9
|
8
|
8
|
7
|
6
|
6
|
6
|
6
|
5
|
5
|
|
| Revenue |
280
N/A
|
303
+8%
|
349
+15%
|
296
-15%
|
249
-16%
|
551
+121%
|
339
-38%
|
343
+1%
|
584
+70%
|
841
+44%
|
744
-12%
|
882
+19%
|
939
+7%
|
932
-1%
|
959
+3%
|
1 082
+13%
|
1 007
-7%
|
969
-4%
|
912
-6%
|
795
-13%
|
723
-9%
|
616
-15%
|
589
-4%
|
514
-13%
|
421
-18%
|
353
-16%
|
299
-15%
|
247
-17%
|
206
-16%
|
183
-11%
|
182
-1%
|
200
+10%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||
| Cost of Revenue |
(214)
|
(230)
|
(263)
|
(224)
|
(190)
|
(409)
|
(251)
|
(253)
|
(434)
|
(629)
|
(564)
|
(673)
|
(731)
|
(739)
|
(760)
|
(857)
|
(798)
|
(767)
|
(725)
|
(641)
|
(585)
|
(496)
|
(479)
|
(413)
|
(326)
|
(261)
|
(206)
|
(159)
|
(129)
|
(112)
|
(111)
|
(125)
|
|
| Gross Profit |
66
N/A
|
73
+10%
|
86
+17%
|
72
-16%
|
60
-17%
|
142
+138%
|
88
-38%
|
89
+1%
|
150
+67%
|
212
+42%
|
179
-16%
|
209
+17%
|
209
0%
|
193
-7%
|
199
+3%
|
225
+13%
|
209
-7%
|
202
-3%
|
187
-8%
|
154
-17%
|
138
-11%
|
119
-13%
|
110
-8%
|
100
-9%
|
95
-6%
|
92
-3%
|
92
0%
|
88
-4%
|
77
-12%
|
70
-9%
|
71
+0%
|
75
+7%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||
| Operating Expenses |
(44)
|
(46)
|
(57)
|
(49)
|
(42)
|
(87)
|
(54)
|
(55)
|
(87)
|
(125)
|
(113)
|
(143)
|
(162)
|
(168)
|
(175)
|
(192)
|
(178)
|
(188)
|
(189)
|
(184)
|
(188)
|
(180)
|
(171)
|
(155)
|
(138)
|
(123)
|
(117)
|
(112)
|
(115)
|
(117)
|
(130)
|
(132)
|
|
| Selling, General & Administrative |
(23)
|
(24)
|
(28)
|
(24)
|
(21)
|
(47)
|
(27)
|
(28)
|
(43)
|
(62)
|
(56)
|
(72)
|
(84)
|
(90)
|
(99)
|
(108)
|
(102)
|
(108)
|
(109)
|
(110)
|
(112)
|
(103)
|
(98)
|
(89)
|
(79)
|
(71)
|
(69)
|
(66)
|
(69)
|
(71)
|
(74)
|
(75)
|
|
| Research & Development |
(21)
|
(23)
|
(29)
|
(25)
|
(21)
|
(40)
|
(25)
|
(26)
|
(43)
|
(62)
|
(57)
|
(71)
|
(78)
|
(78)
|
(85)
|
(93)
|
(85)
|
(80)
|
(79)
|
(74)
|
(76)
|
(77)
|
(71)
|
(65)
|
(56)
|
(52)
|
(48)
|
(46)
|
(46)
|
(46)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(56)
|
(57)
|
|
| Operating Income |
22
N/A
|
27
+22%
|
29
+9%
|
23
-21%
|
18
-22%
|
55
+206%
|
35
-37%
|
34
-1%
|
63
+83%
|
88
+40%
|
67
-24%
|
66
-1%
|
46
-30%
|
25
-46%
|
23
-7%
|
33
+42%
|
31
-6%
|
15
-53%
|
(2)
N/A
|
(30)
-1 281%
|
(50)
-68%
|
(61)
-21%
|
(61)
-1%
|
(55)
+10%
|
(43)
+22%
|
(30)
+29%
|
(25)
+19%
|
(24)
+2%
|
(38)
-58%
|
(47)
-24%
|
(59)
-26%
|
(56)
+6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
3
|
3
|
3
|
5
|
5
|
5
|
6
|
7
|
8
|
7
|
6
|
3
|
(2)
|
5
|
(0)
|
(1)
|
1
|
(6)
|
(3)
|
(1)
|
(3)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
|
| Total Other Income |
1
|
1
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
2
|
(0)
|
0
|
(1)
|
(3)
|
(2)
|
(2)
|
(1)
|
4
|
4
|
5
|
10
|
7
|
6
|
5
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(1)
|
(3)
|
(4)
|
|
| Pre-Tax Income |
24
N/A
|
28
+19%
|
32
+12%
|
26
-19%
|
20
-22%
|
58
+190%
|
38
-34%
|
38
-1%
|
68
+78%
|
94
+40%
|
71
-24%
|
73
+2%
|
53
-27%
|
38
-27%
|
29
-25%
|
38
+31%
|
33
-12%
|
17
-50%
|
7
-58%
|
(25)
N/A
|
(42)
-64%
|
(55)
-33%
|
(62)
-12%
|
(53)
+15%
|
(45)
+16%
|
(35)
+22%
|
(26)
+26%
|
(25)
+2%
|
(38)
-52%
|
(58)
-51%
|
(63)
-8%
|
(59)
+6%
|
|
| Net Income | |||||||||||||||||||||||||||||||||
| Tax Provision |
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(8)
|
(4)
|
(4)
|
(8)
|
(11)
|
(8)
|
(8)
|
(6)
|
(5)
|
(3)
|
(5)
|
(4)
|
(2)
|
(0)
|
4
|
9
|
10
|
11
|
11
|
6
|
2
|
(1)
|
(3)
|
(3)
|
(14)
|
(14)
|
(14)
|
|
| Income from Continuing Operations |
21
|
25
|
28
|
23
|
18
|
51
|
34
|
34
|
60
|
83
|
63
|
64
|
47
|
34
|
26
|
33
|
29
|
15
|
7
|
(22)
|
(32)
|
(46)
|
(51)
|
(42)
|
(39)
|
(32)
|
(27)
|
(28)
|
(41)
|
(72)
|
(76)
|
(73)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Equity Earnings Affiliates |
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
4
|
4
|
6
|
7
|
5
|
5
|
3
|
2
|
(1)
|
(1)
|
1
|
1
|
2
|
1
|
(4)
|
0
|
0
|
|
| Net Income (Common) |
8
N/A
|
7
-15%
|
(24)
N/A
|
(24)
+0%
|
(23)
+4%
|
17
N/A
|
4
-77%
|
4
-5%
|
30
+693%
|
83
+176%
|
63
-24%
|
63
0%
|
46
-27%
|
33
-27%
|
25
-25%
|
37
+50%
|
33
-11%
|
21
-36%
|
14
-36%
|
(17)
N/A
|
(27)
-60%
|
(43)
-59%
|
(49)
-15%
|
(43)
+12%
|
(40)
+6%
|
(31)
+23%
|
(26)
+17%
|
(27)
-3%
|
(40)
-51%
|
(76)
-89%
|
(81)
-7%
|
(78)
+4%
|
|
| EPS (Diluted) |
0.13
N/A
|
0.13
N/A
|
-0.39
N/A
|
-0.65
-67%
|
-0.39
+40%
|
0.3
N/A
|
0.05
-83%
|
0.06
+20%
|
0.45
+650%
|
1.3
+189%
|
0.98
-25%
|
0.98
N/A
|
0.71
-28%
|
0.51
-28%
|
0.38
-25%
|
0.57
+50%
|
0.5
-12%
|
0.32
-36%
|
0.05
-84%
|
-0.06
N/A
|
-0.44
-633%
|
-0.17
+61%
|
-0.8
-371%
|
-0.7
+13%
|
-0.15
+79%
|
-0.13
+13%
|
-0.09
+31%
|
-0.11
-22%
|
-0.16
-45%
|
-0.29
-81%
|
-0.31
-7%
|
-0.3
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
